vs
Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
FREQUENCY ELECTRONICS INC is the larger business by last-quarter revenue ($17.1M vs $13.8M, roughly 1.2× FENNEC PHARMACEUTICALS INC.). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -34.7%, a 45.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 8.3%). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs -26.3%).
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
FEIM vs FENC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.1M | $13.8M |
| Net Profit | $1.8M | $-4.8M |
| Gross Margin | 38.2% | — |
| Operating Margin | 10.0% | -18.5% |
| Net Margin | 10.5% | -34.7% |
| Revenue YoY | 8.3% | 73.8% |
| Net Profit YoY | -32.1% | -141.1% |
| EPS (diluted) | $0.18 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.1M | $13.8M | ||
| Q3 25 | $13.8M | $12.5M | ||
| Q2 25 | $20.0M | $9.7M | ||
| Q1 25 | $18.9M | $8.8M | ||
| Q4 24 | $15.8M | $7.9M | ||
| Q3 24 | $15.1M | $7.0M | ||
| Q2 24 | $15.6M | $7.3M | ||
| Q1 24 | $13.7M | $25.4M |
| Q4 25 | $1.8M | $-4.8M | ||
| Q3 25 | $634.0K | $-638.0K | ||
| Q2 25 | $3.2M | $-3.2M | ||
| Q1 25 | $15.4M | $-1.2M | ||
| Q4 24 | $2.7M | $-2.0M | ||
| Q3 24 | $2.4M | $-5.7M | ||
| Q2 24 | $2.6M | $-5.6M | ||
| Q1 24 | $130.0K | $12.8M |
| Q4 25 | 38.2% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 37.5% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | 44.4% | — | ||
| Q2 24 | 40.3% | — | ||
| Q1 24 | 22.6% | — |
| Q4 25 | 10.0% | -18.5% | ||
| Q3 25 | 2.6% | -1.5% | ||
| Q2 25 | 16.4% | -28.3% | ||
| Q1 25 | 18.3% | -9.2% | ||
| Q4 24 | 16.5% | -11.8% | ||
| Q3 24 | 15.7% | -74.6% | ||
| Q2 24 | 16.0% | -69.4% | ||
| Q1 24 | -3.4% | 54.2% |
| Q4 25 | 10.5% | -34.7% | ||
| Q3 25 | 4.6% | -5.1% | ||
| Q2 25 | 16.0% | -32.7% | ||
| Q1 25 | 81.4% | -13.3% | ||
| Q4 24 | 16.8% | -25.0% | ||
| Q3 24 | 16.1% | -82.2% | ||
| Q2 24 | 16.9% | -76.5% | ||
| Q1 24 | 0.9% | 50.6% |
| Q4 25 | $0.18 | $-0.17 | ||
| Q3 25 | $0.07 | $-0.02 | ||
| Q2 25 | $0.33 | $-0.11 | ||
| Q1 25 | $1.60 | $-0.04 | ||
| Q4 24 | $0.28 | $-0.02 | ||
| Q3 24 | $0.25 | $-0.21 | ||
| Q2 24 | $0.28 | $-0.20 | ||
| Q1 24 | $0.01 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $35.5M |
| Total Assets | $92.3M | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $36.8M | ||
| Q3 25 | $4.5M | $21.9M | ||
| Q2 25 | $4.7M | $18.7M | ||
| Q1 25 | $5.5M | $22.7M | ||
| Q4 24 | $9.7M | $26.6M | ||
| Q3 24 | $16.2M | $40.3M | ||
| Q2 24 | $18.3M | $43.1M | ||
| Q1 24 | $11.7M | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $58.5M | $35.5M | ||
| Q3 25 | $56.3M | $-4.5M | ||
| Q2 25 | $55.6M | $-7.5M | ||
| Q1 25 | $51.8M | $-5.9M | ||
| Q4 24 | $36.2M | $-5.9M | ||
| Q3 24 | $33.2M | $-5.2M | ||
| Q2 24 | $39.8M | $-1.4M | ||
| Q1 24 | $36.7M | $3.0M |
| Q4 25 | $92.3M | $70.6M | ||
| Q3 25 | $93.2M | $49.3M | ||
| Q2 25 | $93.7M | $44.9M | ||
| Q1 25 | $86.4M | $46.4M | ||
| Q4 24 | $77.8M | $44.9M | ||
| Q3 24 | $84.3M | $58.9M | ||
| Q2 24 | $83.3M | $63.2M | ||
| Q1 24 | $77.7M | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-523.0K | $-6.0M |
| Free Cash FlowOCF − Capex | $-1.1M | — |
| FCF MarginFCF / Revenue | -6.6% | — |
| Capex IntensityCapex / Revenue | 3.6% | — |
| Cash ConversionOCF / Net Profit | -0.29× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-523.0K | $-6.0M | ||
| Q3 25 | $1.2M | $1.5M | ||
| Q2 25 | $-155.0K | $-3.7M | ||
| Q1 25 | $-3.6M | $-4.3M | ||
| Q4 24 | $3.8M | $-1.5M | ||
| Q3 24 | $-1.5M | $-2.2M | ||
| Q2 24 | $7.5M | $-8.4M | ||
| Q1 24 | $4.2M | $39.0M |
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $385.0K | — | ||
| Q2 25 | $-786.0K | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $3.9M | — |
| Q4 25 | -6.6% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -20.9% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | -11.8% | — | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 28.4% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | -0.29× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | -0.05× | — | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | — | ||
| Q3 24 | -0.60× | — | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 32.36× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
FENC
Segment breakdown not available.
